COCA-COLA EUROPACIFIC PARTNERS Plc current report, Q2 FY2017

Business Context and Reporting Period

Company: Coca-Cola European Partners Plc (CCEP)
Filing Type: Form 6-K (Interim Results)
Reporting Period: Six months ended 30 June 2017
Business Overview: CCEP is the world's largest independent Coca-Cola bottler by revenue, serving over 300 million consumers across Western Europe. The results reflect the full impact of the 2016 merger with Coca-Cola Enterprises (CCE), Coca-Cola Iberian Partners (CCIP), and Coca-Cola Erfrischungsgetränke (CCEG), as well as the acquisition of Iceland's bottling operations.

Key Financial Metrics

Metric (Six Months Ended 30 June 2017) As Reported (€ million) Comparable Basis (€ million) Comparable & FX-Neutral Growth
Revenue 5,436 5,436 5.0%
Operating Profit 635 688 17.0%
Profit After Taxes 445 478 21.5%
Diluted EPS €0.91 €0.98 21.5%
Volume Growth 3.0% (Comparable basis)
Net Debt (as of 30 June 2017) €6,064 million
Free Cash Flow (Six Months) €222 million

Material Changes vs. Prior Period

  • Revenue Growth: Reported revenue increased 53.5% year-over-year, primarily driven by the inclusion of Germany, Iberia, and Iceland. On a comparable basis, revenue grew 3.0%, or 5.0% on a comparable and FX-neutral basis.
  • Profitability: Reported operating profit rose 102.0% to €635 million due to the merger scope. Comparable operating profit increased 14.0% (17.0% FX-neutral), driven by favorable price/mix, volume growth, and synergy benefits.
  • Geographic Performance:
    • Iberia: Revenue up 8.5% (Q2) driven by Coca-Cola Zero Sugar and sparkling flavors.
    • Germany: Revenue up 7.0% (Q2) with strong volume and price growth.
    • Great Britain: Reported revenue down 0.5% due to a 9.0% decline in the British pound vs. Euro, though FX-neutral growth was strong.
    • France: Revenue up 3.5% with strong volume growth.
  • Brand Performance: Sparkling brands grew 4.0%; Coca-Cola trademark brands grew 3.5% (led by double-digit Zero Sugar growth); Energy and sparkling flavors grew 7.0%.

Guidance, Outlook, and Risks

Full-Year 2017 Outlook

  • Revenue: Low single-digit growth (comparable and FX-neutral).
  • Operating Profit: Growth at the top end of the previously stated high single-digit range.
  • Diluted EPS: Expected to grow 10% to 12% (comparable and FX-neutral). Currency translation is expected to reduce full-year EPS by approximately 2%.
  • Free Cash Flow: Expected at the high end of the €700 million to €800 million range.
  • Capital Expenditures: Approximately €600 million (including €100 million for synergies).
  • Debt Metrics: Year-end net debt to adjusted EBITDA expected to be under 3.0x. Weighted-average cost of debt expected at ~2.0%.

Synergies and Dividends

  • Synergies: On track to achieve pre-tax run-rate savings of €315 million to €340 million by mid-2019. Expected to exit 2017 with approximately half of the target savings.
  • Dividend: Declared quarterly dividend of €0.21 per share, payable 11 September 2017.

Risks and Contingencies

  • Principal Risks: Changing consumer preferences (health impact), legal/regulatory intervention, business integration/synergy realization, cyber attacks, and foreign currency fluctuations.
  • Acquisition Accounting: Finalized fair value adjustments for the merger in Q2 2017, resulting in increases to intangible assets and goodwill, and decreases to property, plant, and equipment. These were not material to the 2016 consolidated financial statements.
  • Tax Matters: The Group maintains provisions for tax uncertainties; actual liabilities could vary significantly based on audit outcomes.

Investor Verification Checklist

  • FX Impact: Verify the sensitivity of future earnings to GBP/EUR and other currency fluctuations, given the significant negative translation impact in the current period.
  • Synergy Realization: Monitor progress against the €315-340 million pre-tax savings target and the associated restructuring cash costs (expected at 2.25x savings).
  • Volume vs. Price: Assess the sustainability of volume growth (3.0% H1) versus price/mix contributions in a competitive market.
  • Debt Leverage: Confirm the trajectory of net debt to adjusted EBITDA remaining under 3.0x given the €6.06 billion net debt position.
  • Regulatory Environment: Review potential impacts of sugar taxes and packaging regulations in key markets like the UK, France, and Iberia.